Compare IDYA & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | TPB |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2019 | 2016 |
| Metric | IDYA | TPB |
|---|---|---|
| Price | $32.39 | $126.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | $49.67 | ★ $115.00 |
| AVG Volume (30 Days) | ★ 858.2K | 318.7K |
| Earning Date | 02-13-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $214,834,000.00 | ★ $435,716,000.00 |
| Revenue This Year | $2,688.43 | $29.51 |
| Revenue Next Year | N/A | $11.08 |
| P/E Ratio | ★ N/A | $657.11 |
| Revenue Growth | ★ 5377.66 | 51.72 |
| 52 Week Low | $13.45 | $51.48 |
| 52 Week High | $39.28 | $130.69 |
| Indicator | IDYA | TPB |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 64.76 |
| Support Level | $31.54 | $123.98 |
| Resistance Level | $34.66 | $130.69 |
| Average True Range (ATR) | 1.38 | 4.18 |
| MACD | -0.32 | 0.31 |
| Stochastic Oscillator | 16.84 | 74.60 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.